Electrophysiological actions of γ-aminobutyric acid and clomethiazole on recombinant GABAA receptors

European Journal of Pharmacology

Volumn 452, Issue 3, 2002, Pages 255-262

  Nelson, Rachael M ^a   Green, A Richard ^a,b   Hainsworth, Atticus H ^a  

^a DE MONTFORT UNIVERSITY   (United Kingdom)

^b ASTRAZENECA   (United Kingdom)

Author keywords

Bicuculline; Clomethiazole; GABA ( aminobutyric acid) mimetic; GABAA receptor; Neuroprotective agent

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID A RECEPTOR BLOCKING AGENT; BICUCULLINE; CLOMETHIAZOLE; RECEPTOR SUBUNIT; RECOMBINANT RECEPTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ELECTROPHYSIOLOGY; GENETIC TRANSFECTION; HUMAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

ANIMALS; CHLORMETHIAZOLE; DOSE-RESPONSE RELATIONSHIP, DRUG; GAMMA-AMINOBUTYRIC ACID; HUMANS; MICE; RECEPTORS, GABA-A; RECOMBINANT PROTEINS;

EID: 0037064220     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(02)02233-1     Document Type: Article

References (40)

1. A receptor channels. J. Neurosci. 21:2001;9083-9091.
2. Chebib M., Johnston G.A. GABA-activated ligand gated ion channels: medicinal chemistry and molecular biology. J. Med. Chem. 43:2000;1427-1447.
3. Cherubini E., Conti F. Generating diversity at GABAergic synapses. Trends Neurosci. 24:2001;155-162.
4. Colado M.I., Granados R., O'Shea E., Esteban B., Green A.R. Role of hyperthermia in the protective action of clomethiazole against MDMA ('ecstasy')-induced neurodegeneration, comparison with the novel NMDA channel blocker AR-R15896AR. Br. J. Pharmacol. 124:1998;479-484.
5. Colado M.I., Esteban B., O'Shea E., Granados R., Green A.R. Studies on the neuroprotective effect of pentobarbitone on MDMA-induced neurodegeneration. Psychopharmacology. 142:1999;421-425.
6. A receptor diversity emerges a unified vision of GABAergic inhibition. Annu. Rev. Pharmacol. Toxicol. 38:1998;321-350.
7. A-receptor complex in rat brain. Br. J. Pharmacol. 98:1989;284-290.
8. Cross A.J., Jones J.A., Baldwin H.A., Green A.R. Neuroprotective activity of chlormethiazole following transient forebrain ischaemia in the gerbil. Br. J. Pharmacol. 104:1991;406-411.
9. Farrar S.J., Whiting P.J., Bonnert T.P., McKernan R.M. Stoichiometry of a ligand-gated ion channel determined by fluorescence energy transfer. J. Biol. Chem. 274:1999;10100-10104.
10. A-receptor heterogeneity in the adult rat brain: differential regional and cellular distribution of seven major subunits. J. Comp. Neurol. 359:1995;154-194.
11. Fritschy J.M., Benke D., Mertens S., Oertel W.H., Bachi T., Mohler H. Five subtypes of type A gamma-aminobutyric acid receptors identified in neurons by double and triple immunofluorescence staining with subunit-specific antibodies. Proc. Natl. Acad. Sci. U. S. A. 89:1992;6726-6730.
12. Green A.R. Clomethiazole (Zendra) in acute ischemic stroke: basic pharmacology and biochemistry and clinical efficacy. Pharmacol. Ther. 80:1998;123-147.
13. A receptor. Neuropharmacology. 35:1996;1243-1250.
14. Green A.R., Hainsworth A.H., Jackson D.M. GABA potentiation: a logical pharmacological approach for the treatment of acute ischaemic stroke. Neuropharmacology. 39:2000;1483-1494.
15. Green A.R., Murray T.K., Misra A., Snape M.F., Jones J.A., Cross A.J. The metabolism of clomethiazole in gerbils and the neuroprotective and sedative activity of the metabolites. Br. J. Pharmacol. 129:2000;95-100.
16. Hadingham K.L., Harkness P.C., McKernan R.M., Quirk K., Le Bourdelles B., Horne A.L., Kemp J.A., Barnard E.A., Ragan C.I., Whiting P.J. Stable expression of mammalian type A gamma-aminobutyric acid receptors in mouse cells: demonstration of functional assembly of benzodiazepine-responsive sites. Proc. Natl. Acad. Sci. U. S. A. 89:1992;6378-6382.
17. A and glycine receptors by chlormethiazole. Eur. J. Pharmacol. 210:1992;239-246.
18. A receptor complex in rat cuneate nucleus in vitro. Br. J. Pharmacol. 80:1983;387-394.
19. Hill-Venning C., Lambert J.J., Peters J.A., Hales T.G. The actions of neurosteroids on inhibitory amino acid receptors. Costa E., Paul S.M. Fidia Research Foundation Symposium: Neurosteroids and Brain Function. vol. 8:1992;683A-684A Thieme, New York.
20. Kim C., Khanna J.M. Determination of chlormethiazole in blood by high performance liquid chromatography. J. Liq. Chromatogr. 6:1983;907-916.
21. Lambert J.J., Hill-Venning C., Peters J.A., Sturgess N.C., Hales T.G. The actions of anesthetic steroids on inhibitory and excitatory amino acid receptors. Barnard E.A., Costa E. Fidia Research Foundation Symposium. vol. 6:1991;93-102 Thieme, New York.
22. Leeb-Lundberg F., Snowman A., Olsen R.W. Interaction of anticonvulsants with the barbiturate-benzodiazepine-GABA receptor complex. Eur. J. Pharmacol. 72:1981;125-129.
23. Lees G. Molecular mechanisms of anaesthesia: light at the end of the channel? Br. J. Anaesth. 81:1998;491-493.
24. A-receptor subtypes really occur in the brain? Trends Neurosci. 19:1996;139-143.
25. A receptors. Brain Res., Brain Res. Rev. 29:1999;196-217.
26. Mody I. Distinguishing between GABA(A) receptors responsible for tonic and phasic conductances. Neurochem. Res. 26:2001;907-913.
27. Moody E.J., Skolnick P. Chlormethiazole: neurochemical actions at the gamma-aminobutyric acid receptor complex. Eur. J. Pharmacol. 164:1989;153-158.
28. Nelson R.M., Green A.R., Lambert D.G., Hainsworth A.H. On the regulation of ischaemia-induced glutamate efflux from rat cortex by GABA; in vitro studies with GABA, clomethiazole and pentobarbitone. Br. J. Pharmacol. 130:2000;1124-1130.
29. A receptors. Br. J. Pharmacol. 134:2001;. (2P).
30. Nelson R.M., Hainsworth A.H., Lambert D.G., Jones J.A., Murray T.K., Richards D.A., Gabrielsson J., Cross A.J., Green A.R. Neuroprotective efficacy of AR-A008055, a clomethiazole analogue, in a global model of acute ischaemic stroke and its effect on ischaemia-induced glutamate and GABA efflux in vitro. Neuropharmacology. 41:2001;159-166.
31. Schwartz-Bloom R.D., Sah R. Gamma-aminobutyric acid(A) neurotransmission and cerebral ischemia. J. Neurochem. 77:2001;353-371.
32. A receptor subtypes. Pharmacol. Rev. 47:1995;181-234.
33. Stubley L.A., Martinez M.A., Karmally S., Lopez T., Cejas P., Eaton M.J. Only early intervention with gamma-aminobutyric acid cell therapy is able to reverse neuropathic pain after partial nerve injury. J. Neurotrauma. 18:2001;471-477.
34. A receptor: dependence on receptor subunit combination. Br. J. Pharmacol. 117:1996;521-527.
35. Thompson S.A., Smith M.Z., Wingrove P.B., Whiting P.J., Wafford K.A. Mutation at the putative GABA(A) ion-channel gate reveals changes in allosteric modulation. Br. J. Pharmacol. 127:1999;1349-1358.
36. A receptor. J. Neurosci. 17:1997;625-634.
37. A-receptor complex in the central nervous system and in the anterior pituitary gland. Naunyn-Schmiedeberg's Arch. Pharmacol. 339:1989;397-402.
38. A receptor beta subunit. Neuron. 12:1994;775-782.
39. A receptors containing one, two, or three different subunits. Eur. J. Pharmacol. 301:1996;207-214.
40. Zhong Y., Simmonds M.A. Interactions between loreclezole, chlormethiazole and pentobarbitone at GABA(A) receptors: functional and binding studies. Br. J. Pharmacol. 121:1997;1392-1396.